|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM258506474 |
003 |
DE-627 |
005 |
20250219205237.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20160229-14
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0861.xml
|
035 |
|
|
|a (DE-627)NLM258506474
|
035 |
|
|
|a (NLM)26985805
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Thanos, Aristomenis
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a A Novel Approach to Understanding Pathogenesis and Treatment of Capillary Dropout in Retinal Vascular Diseases
|
264 |
|
1 |
|c 2016
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 13.12.2016
|
500 |
|
|
|a Date Revised 09.01.2024
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright 2016, SLACK Incorporated.
|
520 |
|
|
|a Capillary dropout is a common sequela of endothelial cell dysfunction that underlies the pathology of multiple retinal vascular diseases, including familial exudative vitreoretinopathy (FEVR). Wide-field fluorescein angiography allowed for identification of areas of capillary inflammatory changes and late-phase angiographic posterior and peripheral vascular leakage (LAPPEL). We propose LAPPEL as a precursor in pathogenesis of capillary dropout and a marker of endothelial cell inflammation in the retina. The authors describe a case of FEVR with significant macular edema associated with LAPPEL, which was successfully treated with topical and intravitreal steroids. The implication for disease mechanism and potential future treatment applications are also discussed
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Glucocorticoids
|2 NLM
|
650 |
|
7 |
|a Ophthalmic Solutions
|2 NLM
|
650 |
|
7 |
|a prednisolone acetate
|2 NLM
|
650 |
|
7 |
|a 8B2807733D
|2 NLM
|
650 |
|
7 |
|a Prednisolone
|2 NLM
|
650 |
|
7 |
|a 9PHQ9Y1OLM
|2 NLM
|
650 |
|
7 |
|a Triamcinolone Acetonide
|2 NLM
|
650 |
|
7 |
|a F446C597KA
|2 NLM
|
700 |
1 |
|
|a Todorich, Bozho
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Trese, Michael T
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 47(2016), 3 vom: 03. März, Seite 288-92
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnas
|
773 |
1 |
8 |
|g volume:47
|g year:2016
|g number:3
|g day:03
|g month:03
|g pages:288-92
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20160229-14
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
912 |
|
|
|a GBV_ILN_1127
|
951 |
|
|
|a AR
|
952 |
|
|
|d 47
|j 2016
|e 3
|b 03
|c 03
|h 288-92
|